Fischer Medical Ventures Limited (BOM:524743)
India · Delayed Price · Currency is INR 25.00
+0.03 (0.12%)
At close: Nov 9, 2026
Fischer Medical Ventures Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 6, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 16,363 | 26,207 | 57,275 | 33,419 | 14 | 13 | |
Market Cap Growth | -72.78% | -54.24% | 71.39% | 231203.81% | 7.62% | 206.08% |
Enterprise Value | 17,201 | 26,154 | 57,247 | 33,399 | 19 | 16 |
Last Close Price | 25.00 | 40.35 | 89.63 | 62.37 | 8.39 | 7.79 |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 6, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 58.85 | 81.36 | 3864.95 | 2424.46 | - | - |
PS Ratio | 4.46 | 8.49 | 51.74 | 159.28 | 8.05 | - |
PB Ratio | 4.23 | 6.80 | 16.95 | 41.20 | -5.43 | -5.85 |
P/TBV Ratio | 4.33 | 6.91 | 17.24 | 42.36 | - | - |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 6, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
EV/Sales Ratio | 4.69 | 8.48 | 51.71 | 159.18 | 10.53 | - |
EV/EBITDA Ratio | 35.37 | 58.27 | 2416.61 | 1888.98 | - | - |
EV/EBIT Ratio | 36.78 | 60.18 | 3346.01 | 1990.88 | 123.50 | - |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 6, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Debt / Equity Ratio | 0.28 | 0.28 | 0.25 | 0.02 | -2.15 | -1.70 |
Debt / EBITDA Ratio | 2.21 | 2.31 | 33.94 | 0.90 | - | - |
Net Debt / Equity Ratio | 0.21 | 0.21 | -0.49 | -0.45 | -2.01 | -1.63 |
Net Debt / EBITDA Ratio | 1.69 | 1.83 | -70.07 | -20.51 | - | - |
Net Debt / FCF Ratio | - | -0.63 | 1.80 | 4.63 | -3.67 | -2.11 |
Asset Turnover | - | 0.55 | 0.41 | 0.48 | 0.66 | - |
Inventory Turnover | - | 17.98 | 13.46 | - | - | - |
Quick Ratio | - | 1.24 | 3.24 | 15.97 | 4.32 | 0.04 |
Current Ratio | - | 1.62 | 3.62 | 18.37 | 5.19 | 0.12 |
Return on Equity (ROE) | - | 8.58% | 0.58% | 4.55% | - | - |
Return on Assets (ROA) | - | 4.81% | 0.39% | 2.42% | 3.52% | -53.14% |
Return on Invested Capital (ROIC) | 6.78% | 9.08% | 0.86% | 6.47% | 40.16% | - |
Return on Capital Employed (ROCE) | - | 10.50% | 0.50% | 2.00% | 5.00% | 82.20% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 6, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Earnings Yield | 1.70% | 1.23% | 0.03% | 0.04% | -2.53% | -17.33% |
FCF Yield | -7.93% | -4.95% | -1.61% | -0.24% | -10.10% | -13.18% |
Dividend Yield | 0.20% | 0.13% | 0.06% | - | - | - |
Payout Ratio | 11.77% | 0.85% | - | - | - | - |
Buyback Yield / Dilution | - | -26.45% | -223.98% | -9752.91% | - | - |
Total Shareholder Return | 0.20% | -26.32% | -223.92% | -9752.91% | - | - |